ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 263.80
-2.40 (-0.90%)
At close: Jun 8, 2026
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 58.98 billion as of June 8, 2026. Its market cap has increased by 60.05% in one year.
Market Cap
58.98B
Enterprise Value
57.84B
Revenue
6.56B
Ranking
n/a
PE Ratio
46.07
Stock Price
263.80
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 58.98B, an increase of 753.79%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 58.98B | 16.64% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 97.22B |
| Coloplast | 86.40B |
| Demant | 53.19B |
| H. Lundbeck | 42.96B |
| Zealand Pharma | 22.92B |
| Ambu A/S | 17.48B |
| Bavarian Nordic | 13.97B |